Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut MicrobiotaSa Yang(Hunan Academy of Agricultural Sciences), Ning Kang(Tianjin University of Traditional Chinese Medicine)Frontiers in PharmacologyJuly 8, 202210.3389/fphar.2022.913378Cited by 50SaveCiteExport RISWatch citationsRelated PapersBerberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways|Biomedicine & Pharmacotherapy|2020|214